Practical strategies for targeting NF-kappaB and NADPH oxidase may improve survival during lethal influenza epidemics

Medical Hypotheses

Volumn 74, Issue 1, 2010, Pages 18-20

  McCarty, Mark F ^a   Barroso Aranda, Jorge ^a   Contreras, Francisco ^a  

^a Oasis of Hope Hospital   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; BILIRUBIN; BILIVERDIN; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSELTAMIVIR; PHYCOCYANOBILIN; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RIBAVIRIN; SALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME INHIBITION; EPIDEMIC; HUMAN; INFLUENZA; LETHALITY; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MACROPHAGE ACTIVATION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; BIRDS; DISEASE OUTBREAKS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; LUNG; MACROPHAGES; MICE; MODELS, THEORETICAL; NADPH OXIDASE; NF-KAPPA B; PHYCOBILINS; PHYCOCYANIN; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; AVES; MUS; RODENTIA; SPIRULINA;

EID: 70450255243     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.04.052     Document Type: Article

References (40)

1. Fleming D.M. Managing influenza: amantadine, rimantadine and beyond. Int J Clin Pract 55 3 (2001) 189-195
2. Gubareva L.V., Webster R.G., and Hayden F.G. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res 53 1 (2002) 47-61
3. Alexander M.E., Bowman C.S., Feng Z., Gardam M., Moghadas S.M., Rost G., et al. Emergence of drug resistance. implications for antiviral control of pandemic influenza. Proc Biol Sci 274 1619 (2007) 1675-1684
4. Ludwig S., Planz O., Pleschka S., and Wolff T. Influenza-virus-induced signaling cascades: targets for antiviral therapy?. Trends Mol Med 9 2 (2003) 46-52
5. Nimmerjahn F., Dudziak D., Dirmeier U., Hobom G., Riedel A., Schlee M., et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 85 Pt 8 (2004) 2347-2356
6. Mazur I., Wurzer W.J., Ehrhardt C., Pleschka S., Puthavathana P., Silberzahn T., et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 9 7 (2007) 1683-1694
7. Suliman H.B., Ryan L.K., Bishop L., and Folz R.J. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 280 1 (2001) L69-L78
8. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 9348 (2002) 1831-1837
9. Bernasconi D., Amici C., La F.S., Ianaro A., and Santoro M.G. The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J Biol Chem 280 25 (2005) 24127-24134
10. Snelgrove R.J., Edwards L., Rae A.J., and Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36 6 (2006) 1364-1373
11. Pahl H.L., and Baeuerle P.A. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol 69 3 (1995) 1480-1484
12. Knobil K., Choi A.M., Weigand G.W., and Jacoby D.B. Role of oxidants in influenza virus-induced gene expression. Am J Physiol 274 1 Pt 1 (1998) L134-L142
13. Flory E., Kunz M., Scheller C., Jassoy C., Stauber R., Rapp U.R., et al. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem 275 12 (2000) 8307-8314
14. Wurzer W.J., Ehrhardt C., Pleschka S., Berberich-Siebelt F., Wolff T., Walczak H., et al. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem 279 30 (2004) 30931-30937
15. Wei L., Sandbulte M.R., Thomas P.G., Webby R.J., Homayouni R., and Pfeffer L.M. NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281 17 (2006) 11678-11684
16. Kopp E., and Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265 5174 (1994) 956-959
17. Yin M.J., Yamamoto Y., and Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396 6706 (1998) 77-80
18. Morris H.G., Sherman N.A., McQuain C., Goldlust M.B., Chang S.F., and Harrison L.I. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. Ther Drug Monit 7 4 (1985) 435-438
19. Whittle B.J., Hansen D., and Salmon J.A. Gastric ulcer formation and cyclo-oxygenase inhibition in cat antrum follows parenteral administration of aspirin but not salicylate. Eur J Pharmacol 116 1-2 (1985) 153-157
20. Rosenkranz B., Fischer C., Meese C.O., and Frolich J.C. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol 21 3 (1986) 309-317
21. Zambraski E.J., Atkinson D.C., and Diamond J. Effects of salicylate vs. aspirin on renal prostaglandins and function in normal and sodium-depleted dogs. J Pharmacol Exp Ther 247 1 (1988) 96-103
22. Ranjan P., Anathy V., Burch P.M., Weirather K., Lambeth J.D., and Heintz N.H. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid Redox Signal 8 9-10 (2006) 1447-1459
23. Goyal P., Weissmann N., Grimminger F., Hegel C., Bader L., Rose F., et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radical Biol Med 36 10 (2004) 1279-1288
24. 4 redox-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 293 1 (2007) L170-L181
25. 2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 85 3 (1990) 739-745
26. Nencioni L., Iuvara A., Aquilano K., Ciriolo M.R., Cozzolino F., Rotilio G., et al. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J 17 6 (2003) 758-760
27. Cai J., Chen Y., Seth S., Furukawa S., Compans R.W., and Jones D.P. Inhibition of influenza infection by glutathione. Free Radical Biol Med 34 7 (2003) 928-936
28. N-acetylcysteine. Altern Med Rev 2000;5(5):467-1.
29. Ungheri D., Pisani C., Sanson G., Bertani A., Schioppacassi G., Delgado R., et al. Protective effect of n-acetylcysteine in a model of influenza infection in mice. Int J Immunopathol Pharmacol 13 3 (2000) 123-128
30. De F.S., Grassi C., and Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 10 7 (1997) 1535-1541
31. Akaike T., Okamoto S., Sawa T., Yoshitake J., Tamura F., Ichimori K., et al. 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci USA 100 2 (2003) 685-690
32. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 93 6 (1996) 2448-2453
33. Hashiba T., Suzuki M., Nagashima Y., Suzuki S., Inoue S., Tsuburai T., et al. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther 8 19 (2001) 1499-1507
34. Lanone S., Bloc S., Foresti R., Almolki A., Taille C., Callebert J., et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19 13 (2005) 1890-1892
35. Matsumoto H., Ishikawa K., Itabe H., and Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 291 1-2 (2006) 21-28
36. Jiang F., Roberts S.J., Datla S., and Dusting G.J. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48 5 (2006) 950-957
37. McCarty M.F. "Iatrogenic Gilbert syndrome" - a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypoth 69 (2007) 974-994
38. McCarty M.F. Clinical potential of spirulina as a source of phycocyanobilin. J Med Food 10 (2007) 566-570
39. Ghezzi P., and Ungheri D. Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. Int J Immunopathol Pharmacol 17 1 (2004) 99-102
40. Garozzo A., Tempera G., Ungheri D., Timpanaro R., and Castro A. N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection. Int J Immunopathol Pharmacol 20 2 (2007) 349-354